While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author of today’s article recommends gaining […]
read more
The Tailwinds Behind Biotech – And How Both Traders And Investors Can Profit With ETFs
“While volatility still permeates the broad market, one segment has seen a fairly consistent upward trend through the bulk of the year. That segment is, of course, biotech”, notes an […]
read more
2 Truly Transformative Tech Trends To Focus On – And 2 Stocks Set To Profit From Those Trends
When it comes to technology trends, the cloud computing trend that generated so much success for the largest tech companies can no longer really be considered new and transformative. So […]
read more
Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication at this point whose vaccine […]
read more
4 Small-Caps Set To Surge
Long periods of underperformance by an asset class have historically been followed by extended periods of outperformance, so when it comes to finding the next big stock winners, investors may […]
read more
After An Incredible 4748% Surge, Still Plenty Of Room To Run For Vaxart?
Shares of vaccine specialist Vaxart have exploded an astonishing 4748% so far this year, as investors have piled into the company on the hopes that it – and its “one-of-its-kind” […]
read more
Electoral Options: How – And Why – Traders Are Pricing In A Lot Of Risk In Early November
Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one particular point in time in […]
read more
4 Biotech Stocks Worthy Of Close Attention
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly attributed to the work toward […]
read moreThe Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
What’s clear is that, having surged 2,819% in the past 12 months (and 351% so far this year in the face of a market meltdown), this stock is the best-performing […]
read moreA Better Way To Play The Earnings Game?
Given the ability of earnings reports to catapult stock prices higher in a short period of time, the authors of today’s article state “It’s no wonder why options traders tend […]
read more